DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,038,387 | -28.4% | 1,116,742 | +2.5% | 0.00% | -33.3% |
| Q2 2023 | $32,156,989 | +37.1% | 1,089,698 | +7.0% | 0.01% | +20.0% |
| Q1 2023 | $23,454,813 | -14.3% | 1,018,004 | +3.4% | 0.01% | -16.7% |
| Q4 2022 | $27,370,352 | +0.2% | 984,191 | +10.6% | 0.01% | 0.0% |
| Q3 2022 | $27,313,000 | +4.2% | 889,968 | -0.1% | 0.01% | 0.0% |
| Q2 2022 | $26,210,000 | -10.1% | 890,618 | -1.7% | 0.01% | +20.0% |
| Q1 2022 | $29,153,000 | -31.8% | 906,228 | -5.5% | 0.01% | -28.6% |
| Q4 2021 | $42,775,000 | -10.9% | 959,089 | +0.8% | 0.01% | -12.5% |
| Q3 2021 | $48,016,000 | -37.5% | 951,725 | -2.8% | 0.01% | -42.9% |
| Q2 2021 | $76,798,000 | +78.5% | 979,058 | +29.9% | 0.01% | +75.0% |
| Q1 2021 | $43,033,000 | -33.9% | 753,634 | -3.1% | 0.01% | -38.5% |
| Q4 2020 | $65,145,000 | +130.4% | 777,745 | -1.4% | 0.01% | +116.7% |
| Q3 2020 | $28,270,000 | +40.5% | 789,018 | -5.2% | 0.01% | +20.0% |
| Q2 2020 | $20,125,000 | +64.6% | 832,260 | +19.2% | 0.01% | +25.0% |
| Q1 2020 | $12,225,000 | +10.5% | 698,199 | +10.0% | 0.00% | +100.0% |
| Q4 2019 | $11,062,000 | +10.3% | 635,012 | -3.0% | 0.00% | 0.0% |
| Q3 2019 | $10,027,000 | -22.1% | 654,451 | +5.5% | 0.00% | -33.3% |
| Q2 2019 | $12,873,000 | -9.7% | 620,050 | +1.0% | 0.00% | -25.0% |
| Q1 2019 | $14,257,000 | +12.4% | 613,987 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,685,000 | -2.7% | 613,964 | +2.4% | 0.00% | +33.3% |
| Q3 2018 | $13,041,000 | +357.6% | 599,859 | +220.9% | 0.00% | +200.0% |
| Q2 2018 | $2,850,000 | -13.9% | 186,934 | +11.2% | 0.00% | 0.0% |
| Q1 2018 | $3,309,000 | – | 168,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |